5.975
Tenax Therapeutics Inc Azioni (TENX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
100.00%
-
|
-24.40 | 9.2378 | 7.344 | - |
|
55.43%
11.34
|
7.2948 | 4.6189 | 3.672 | 3.9083 |
Operating Income/Loss |
64.23%
-11.34
|
-31.69 | 4.6189 | 3.672 | -3.9083 |
Income/Loss From Continuing Operations Before Tax |
66.08%
-10.41
|
-6.267 | 3.9605 | -3.5757 | -3.7988 |
Income/Loss From Continuing Operations After Tax |
66.08%
-10.41
|
-6.267 | 3.9605 | -3.5757 | -3.7988 |
|
66.08%
-10.41
|
-6.267 | 3.9605 | -3.5757 | -3.7988 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
100.00%
-
|
22.67 | - | - | - |
Basic Average Shares |
36.58
|
- | - | - | - |
Diluted Average Shares |
36.58
|
- | - | - | - |
Basic Earnings Per Share |
-0.28
|
- | - | - | - |
Diluted Earnings Per Share |
-0.28
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):